UniProt ID | CD40L_HUMAN | |
---|---|---|
UniProt AC | P29965 | |
Protein Name | CD40 ligand | |
Gene Name | CD40LG | |
Organism | Homo sapiens (Human). | |
Sequence Length | 261 | |
Subcellular Localization |
Cell membrane Single-pass type II membrane protein . Cell surface . CD40 ligand, soluble form: Secreted . |
|
Protein Description | Cytokine that binds to CD40/TNFRSF5. [PubMed: 1280226 Costimulates T-cell proliferation and cytokine production. Its cross-linking on T-cells generates a costimulatory signal which enhances the production of IL4 and IL10 in conjunction with the TCR/CD3 ligation and CD28 costimulation] | |
Protein Sequence | MIETYNQTSPRSAATGLPISMKIFMYLLTVFLITQMIGSALFAVYLHRRLDKIEDERNLHEDFVFMKTIQRCNTGERSLSLLNCEEIKSQFEGFVKDIMLNKEETKKENSFEMQKGDQNPQIAAHVISEASSKTTSVLQWAEKGYYTMSNNLVTLENGKQLTVKRQGLYYIYAQVTFCSNREASSQAPFIASLCLKSPGRFERILLRAANTHSSAKPCGQQSIHLGGVFELQPGASVFVNVTDPSQVSHGTGFTSFGLLKL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MIETYNQTSPR ----CCCCCCCCCCC | 19.49 | 28796482 | |
5 | Phosphorylation | ---MIETYNQTSPRS ---CCCCCCCCCCCH | 7.77 | 28796482 | |
26 | Phosphorylation | ISMKIFMYLLTVFLI HHHHHHHHHHHHHHH | 6.44 | 22210691 | |
29 | Phosphorylation | KIFMYLLTVFLITQM HHHHHHHHHHHHHHH | 13.45 | 22210691 | |
154 | Phosphorylation | TMSNNLVTLENGKQL EEECCEEEEECCEEE | 31.36 | 22210691 | |
162 | Phosphorylation | LENGKQLTVKRQGLY EECCEEEEEEECEEE | 22.84 | 23532336 | |
169 | Phosphorylation | TVKRQGLYYIYAQVT EEEECEEEEEEEEEE | 8.47 | 24043423 | |
170 | Phosphorylation | VKRQGLYYIYAQVTF EEECEEEEEEEEEEE | 7.78 | 24043423 | |
172 | Phosphorylation | RQGLYYIYAQVTFCS ECEEEEEEEEEEECC | 3.78 | 24043423 | |
176 | Phosphorylation | YYIYAQVTFCSNREA EEEEEEEEECCCCCH | 13.57 | 24043423 | |
179 | Phosphorylation | YAQVTFCSNREASSQ EEEEEECCCCCHHCC | 34.43 | 24043423 | |
240 | N-linked_Glycosylation | PGASVFVNVTDPSQV CCCEEEEEECCHHHC | 21.36 | 11676606 | |
240 | N-linked_Glycosylation | PGASVFVNVTDPSQV CCCEEEEEECCHHHC | 21.36 | 11676606 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CD40L_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CD40L_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
HPTR_HUMAN | HPR | physical | 10085035 | |
APOA1_HUMAN | APOA1 | physical | 10085035 | |
RN128_HUMAN | RNF128 | physical | 18641297 | |
TNR5_HUMAN | CD40 | physical | 23918987 | |
TRAF2_HUMAN | TRAF2 | physical | 23918987 | |
BIRC2_HUMAN | BIRC2 | physical | 23918987 | |
BIRC3_HUMAN | BIRC3 | physical | 23918987 | |
TRAF1_HUMAN | TRAF1 | physical | 23918987 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00080 | Systemic lupus erythematosus | |||||
H00093 | Combined immunodeficiencies (CIDs), including the following nine diseases: X-linked hyper IgM syndro | |||||
OMIM Disease | ||||||
308230 | X-linked immunodeficiency with hyper-IgM 1 (HIGM1) | |||||
Kegg Drug | ||||||
D05777 | Ruplizumab (USAN/INN) | |||||
D06193 | Toralizumab (USAN/INN) | |||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...